You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Provides a clear and concise summary of the scientific data on treatment efficacy which can contribute to a better understanding among the general public on the status of the field of psychiatric treatment research for the severely mentally ill. Includes efficacy of treatments for: schizophrenia, bipolar disorder, major depression, panic disorder, obsessive-compulsive disorder, geropsychiatric patients with severe mental illness, psychiatric disorders in children and adolescents, and psychiatric rehabilitation. Charts and tables.
None
Each issue lists papers published during the preceding year.
Clinical trials are the most definitive tool for evaluation of the applica bility of clinical investigations. The main objective of clinical investiga tions is to assess the potential value of a therapeutic entity in the treat ment or prophylaxis of a disease or a condition. It is also deemed necessary at this stage to obtain information regarding the undesirable side effects, associated risks, and their interrelationship with clinical assessments. Most of these clinical investigations conform, in some form or fashion, to the guidelines adopted by the Food and Drug Administration (FDA) for a given class of compounds. Clinical investigations in the past have not included specific studies in special or subpopulations, e.g., the elderly. Because of an ever-increasing elderly population, newer policies for clinical investigations are now being debated with the recognition of enhanced drug sensitivity in this special population. This key research activity can lead not only to improved health care in the elderly but also to control of its costs.
Kitty Dukakis has battled debilitating depression for more than twenty years. Coupled with drug and alcohol addictions that both hid and fueled her suffering, Kitty's despair was overwhelming. She tried every medication and treatment available; none worked for long. It wasn't until she tried electroconvulsive therapy, or ECT, that she could reclaim her life. Kitty's dramatic first-person account of how ECT keeps her illness at bay is half the story of Shock. The other half, by award winning medical reporter Larry Tye, is an engrossing look at the science behind ECT and its dramatic yet subterranean comeback. This book presents a full picture of ECT, analyzing the treatment's risks along with...
A leading textbook in the internal medicine field for more than 25 years, this publication is based on a continually updated electronic database, where new and updated information is fully integrated monthly, and the entire database published annually in print. Each annual edition contains up to as much as 40% new and updated information, published in 2 volumes with four-color illustrations throughout. The text covers all of internal medicine, plus bio-terrorism and medical emergencies, dermatology, office gynecology, neurology, and psychiatry. More than 200 expert sub-specialists with extensive clinical experience provide clear, actionable diagnosis and treatment recommendations. Key recommendations are readily accessible in the 778 tables on drug regimens, differential diagnoses, common presenting symptoms, and risk factors. References to current best evidence support the recommendations and lead the reader to scientifically sound research.